African Journal of
Microbiology Research

  • Abbreviation: Afr. J. Microbiol. Res.
  • Language: English
  • ISSN: 1996-0808
  • DOI: 10.5897/AJMR
  • Start Year: 2007
  • Published Articles: 5002

Review

Importance of biofilm in medical sciences: With special reference to uropathogens

Ghanwate Niraj A.
  • Ghanwate Niraj A.
  • Department of Microbiology, Sant Gadge Baba Amravati University, Amravati, India.
  • Google Scholar
Tiwari Anjali A.
  • Tiwari Anjali A.
  • Department of Biotechnology, Sant Gadge Baba Amravati University, Amravati, India.
  • Google Scholar
Thakare P. V.
  • Thakare P. V.
  • Department of Microbiology, Sant Gadge Baba Amravati University, Amravati, India.
  • Google Scholar


  •  Received: 23 June 2016
  •  Accepted: 17 August 2016
  •  Published: 14 September 2016

References

Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ (2003). Intracellular bacterial biofilm-like Pods in Urinary tract infections. Science 301:105-107.
Crossref

 

Anderson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S, Svanborg C (1991). Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infec. Immun. 59:2915-2921.

 
 

Balaban N, Gov Y, Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, Orlando F, D'amato G, Saba V, Scalise G, Bernes S (2004). A chimeric pep-tide composed of a dermaseptin derivative and an RNA III-inhibiting peptide prevents graft-associated infections by antibiotic-resistant staphylococci. Antimicrob. Agents Chemother. 48:2544-2550.
Crossref

 
 

Beloin C, Roux A, Ghigo JM (2008). Escherichia coli biofilms. Curr. Top. Microbiol. Immunol. 322:249-289.
Crossref

 
 

Brisset L, Vernet-Garnier V, Carquin J, Burde A, Flament JB, Choisy C (1996). In vivo and in vitro analysis of the ability of urinary catheters to microbial colonization. Pathol. Biol. 44:397-404.

 
 

Caiazza NC, O' Toole GA (2012). Sad B is required for the transition from reversible to irreversible attachment during biofilm formation by Pseudomonas aeruginosa PA1. J. Bacteriol. 189:4476-4485.

 
 

Carson L, Gorman SP, Gilmore BF (2010). The use of lytic bacteriophages in the prevention and eradication of biofilms of Proteus mirabilis and Escherichia coli. FEMS Immunol. Med. Microbiol. 59:447-455.
Crossref

 
 

Cegelski L, Pinkner JS, Hammer ND (2009). Small- molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat. chem. Biol. 51: 913-919.
Crossref

 
 

Choong S, Wood S, Fry C, Whitfield H (2001). Catheter associated urinary tract infection and encrustation. Int. J. Antimicrob. Agents. 17:305-310.
Crossref

 
 

Christensen GD, Simpson WA, Younger JA, Baddour LM, Barrett FF,Melton DM, Beachey EH. Adherence of coagulase negative Staphylococci to plastic tissue culture a quantitative model for the adherence of staphylococci to medical devices. J. Clin. Microbiol. 22:996-1006

 
 

Costerton JW, Cheng KJ, Gessey GG (1987). Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 41:435-464.
Crossref

 
 

Costerton JW, Ellis B, Lam K, Johnson F, Khoury AE (1994). Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria. Antimicrob. Agents Chemother. 38:2803-2809.
Crossref

 
 

Costerton JW, Montanaro L, Arciola CR (2007). Bacterial communications in implant infections: a target for an intelligence war. Int. J. Artif. Organs 30(9):757-763.

 
 

Curtin JJ, Donlan RM (2006). Using bacteriophages to reduce formation of catheter-associated biofilms by Staphylococcus epidermidis. Antimicrob. Agents Chemother. 50:1268-1275.
Crossref

 
 

Danese PN, Pratt LA, Kolter R (2000). Exopolysaccharide production is required for development of Escherichia coli. K-12 biofilm architecture. J. Bacteriol. 182:3593-3596.
Crossref

 
 

Davenport K, Keeley FX (2005). Evidence for the use of silver-alloy-coated urethral catheters. J. Hosp. Inf. 60:298-303.
Crossref

 
 

Donlan RM (2001). Biofilms and device-associated infections. Emerg Infect Dis. 7:277.
Crossref

 
 

Donlan RM (2002). Biofilms: microbial life on Surfaces. Emerg. Infect. Dis. 9:88-890.
Crossref

 
 

Elliott TS, Moss HA, Tebbs SE, Wilson IC, Bonser RS, Graham TR (1992). Novel approach to investigate a source of microbial contamination of central venous catheters. Eur. J. Clin. Microbiol. Infect. Dis. 15:13-20

 
 

Ethers LJ, Bouwer JE (1999). RP4 Plasmid transfer among species of Pseudomonas in a biofilm reacter. Water Sci. Technol. 7:163-171.

 
 

Fey PD (2010). Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr. Opin. Microbiol. 13:610-615.
Crossref

 
 

Fisher LE, Hook AL, Ashraf W, Yousef A, Barrett DA, Scurr DJ, Chen X, Smith EF, Fay M, Parmenter CDJ, et al (2015). Biomaterial modification of urinary catheters with antimicrobials to give long-term broadspectrum antibiofilm activity. J. Control Release 202:57-64.
Crossref

 
 

Foo LY, Lu Y, Howell AB, Vorsa N (2000). A-type proantho-cyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Escherichia coli. J Natural Prod. 63:1225-1228.
Crossref

 
 

Foo LY, Lu Y, Howell AB, Vorsa N (2000). The structure of cranberry proanthocyanidins which inhibit adherence of uropathogenic P-fimbriated Escherichia coli in vitro. Phyto-chemistry 54:173-181.
Crossref

 
 

Foxman B (2002). Epidemiology of urinary tract infection: Incidence morbidity and economic costs. Am. J. Med. 113:5S-13S.
Crossref

 
 

Freeman DJ, Falkiner FR, Keane CT (1989). A new method for the detection of the slime production by the coagulase negative Staphylococci. J. Clin. Pathol. 42: 872-874.
Crossref

 
 

Forster T, Fu W, Mayer O, Curtin J, Lehman SM, Donlan RM (2010). Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob. Agents Chemother. 54:397-404.
Crossref

 
 

Lohr G, Beikler T, Podbielski A, Standar K, Redanz S, Hensel A (2011). Polyphenols from Myrothamnus flabellifolia Welw. Inhibit in vitro adhesion of Porphyromonas gingivalis and exert anti-inflammatory cytoprotective effects in KB cells. J. Clin. Periodontol. 38:457-469.
Crossref

 
 

Garibaldi RA, Miller WA, Hebertson RM, Burke JP (1977). Antmicrobial prophylaxis for catheter-associated bacteriuria. Antmicrob. Agents Chemother. 11:240-243.
Crossref

 
 

Ghanwate NA (2012). Biofilm eradication studies on Uropathogenic E.coli using Ciprofloxacin and Nitofurantion. Int. J. Pharm. Biomed. Res. pp. 127-131.

 
 

Ghanwate NA, Thakare PV, Bhise PR, Tayde S (2014). Prevention of Biofilm formation in Urinary catheters by treatment with Antibiofilm agent. Int. J. Sci. Res. 3:714-717.

 
 

Giwercman B, Jensen E T, Hoiby N, Kharazmi A, Costerton W (1991). Induction of beta-lactamase production in Pseudomonas aeruginosa biofilm. Antimicrob. Agents Chemother. 35:1008-1010.
Crossref

 
 

Gorman SP, Jones DS (2003). Complications of urinary devices, in: Wilson, M Ed. Medical Implications of Biofilms. Cambridge University Press, Cambridge. UK. pp. 136-170.
Crossref

 
 

Grinholc M, Richter M, Nakonieczna J, Fila G, Bielawski KP (2011). The connection between grand SCC mec elements of Staphylococcus aureus strains and their response to photodynamic inactivation. Photomed. Laser Surg. 29:413-419.
Crossref

 
 

Grinholc M, Szramka B, Kurlenda J, Graczyk A, Bielawski KP (2008). Bactericidal effect of photodynamic inactivation against methicillin-resistant and methicillin-susceptible Staphylococcus aureus is strain-dependent. J. Photochem. Photobiol. 90:57-63.
Crossref

 
 

Grinholc M, Zawacka-Pankau J, Gwizdek-Wiśniewska A, Bielawski KP (2010). Evaluation of the role of the pharmacological inhibition of Staphylococcus aureus multidrug resistant pumps and the variable levels of the uptake of the sensitizer in the strain-dependent response of Staphylococcus aureus to PPArg2-based photo dynamic inactivation. Photochem. Photobiol. 86:1118-1126.
Crossref

 
 

Guiton PS, Hung CS, Kline KA, Roth R, Kau AL, et al (2009). Contribution of autolysin and Sortase A during Enterococcus faecalis DNA-dependent biofilm development. Infect. Immun. 77:3626-38.
Crossref

 
 

Hamblin MR, Hasan T (2004). Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photo boil. Sci. 3:436-450.

 
 

Hensel Z, Xiao J (2009). A mechanism for stochastic decision making by bacteria. Chem. BioChem. 10: 974-976.
Crossref

 
 

Hinsa SM, Espinosaurgel E, Ramos JL, O' Toole GA (2003). Transition from reversible to irreversible attachment during biofilm formation by Pseudomonas fluorescenes WCS365 requires an ABC transporter and a large secreted protein. Mol. Micobiol. 49:905-918.
Crossref

 
 

Holland SP, Mathias RG, Morck DW, Chiu J, Slade SG (2000). Diffuse lamellar keratitides related to endotoxins released from sterilize reservoir biofilm. Opthalmology 107:1227-1234.
Crossref

 
 

Hong SH, Wang X, Wood TK (2010). Controlling biofilm formation, prophage excision and cell death by rewiring global regulator H-NS of Escherichia coli. Microb. Biotechnol. 3:344-356.
Crossref

 
 

Hooton TM, Bradley SF, Cardenas DD, Colgan R, Geerlings SE, Rice JC, Saint S, Schaeer AJ, Tambayh PA, Tenke P, Nicolle LE (2010). Diagnosis, Prevention, and Treatment of Catheter Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis. 50(5):625-63.
Crossref

 
 

Hull RA, Donovan WH, Del Terzo M, Stewart C, Rogers M, Darouiche RO (2002). Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect. Immun. 70:6481-6484.
Crossref

 
 

Imamura Y, Higashiyama Y, Tomono K, Izumikawa K, Yanagihara K, Ohno H, Miyazaki Y, Hirakata Y, Mizuta Y, J Kadota, et al (2005). Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane. Antimicrob. Agents Chemother. 49:1377-1380.
Crossref

 
 

Jacobsen SM, Stickler DJ, Mobley HL, Shirtli ME (2008). Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin Microbiol. Rev. 21:26-59.
Crossref

Jepson RG, Mihaljevic L, Craig J (2001). Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews. 3: 
Crossref

 

Kaplan JB (2010). Biofilm dispersal mechanisms, clinical implications, and potential therapeutic uses. J. Dental Res. 89:205-218.
Crossref

 
 

Karatan E, Watnik P (2009). Signals, regulatory networks and materials that build and break bacterial biofilm. Microbiol. Mol. Biol. Rev. 73:310-347.
Crossref

 
 

Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004). Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230:13-18.
Crossref

 
 

Keren I, Shah D, Spoering A, Kaldalu N, Lewis K (2004). Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186:8172-8180.
Crossref

 
 

Kharidia R, Liang J (2011). The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms. J. Microbiol. 49:663-668.
Crossref

 
 

Lappinscott HM, Bass C (2001). Biofilm formation: attachment, growth, and detachment of microbes from surfaces. Am. J. Infect. Control 29:250-251.
Crossref

 
 

Laue H, Schenk A, Li H (2006). Contribution of alginate and levan production to biofilm formation by Pseudomonas syrinage. Microbiology 152(10):2909-2918.
Crossref

 
 

Lellouche J, Friedman A, Gedanken A, Banin E (2012). Antibacterial and Antibiofilm properties of yttrium fluoride nanoparticles. Int. J. Nanomed. 7:5611-5624.

 
 

Lellouche J, Kahana E, Elias S, Gedanken A, Banin E (2009). Antibiofilm activity of nanosized magnesium fluoride. Biomaterials 30:5969-5978.
Crossref

 
 

Lemon KP, Higgins DE, Kolter (2007). Flagellar motility is critical for Listeria monocytogens biofilm formation. J. Bacteriol. 12:4418-4424.
Crossref

 
 

Lewis K (2001). Riddle of biofilm resistance. Antimicrobial Agents and Chemother 2001. 45:999-1007.
Crossref

 
 

Lewis K (2005). Persister cells and the riddle of biofilm survival. Biochemistry 70:267-274.
Crossref

 
 

Lewis K (2008). Multidrug tolerance of biofilms and persister cells. Curr. Top. Microbiol. Immun. 322:107-131.
Crossref

 
 

Lu TK, Collins JJ (2007). Dispersing biofilms with engineered enzymatic bacteriophage. Proc. Natl Acad. Sci. United States Am. 104:11197-1202.
Crossref

 
 

Mack D, Becker P, Chatterjee I, Dobinsky S, Knobloch JK, Peters G, Rohde H, Herrmann M. (2004). Mechanisms of biofilm formation in Staphylococcus epidermidis and Staphylococcus aureus: functional molecules, regulatory circuits, and adaptive responses. Int. J. Med. Microbiol. 294:203-212.
Crossref

 
 

Maria K, Maria H, Scott J (2014). Bacterial Biofilms: Development, Dispersal, and Therapeutic Strategies in the Dawn of the Postantibiotic Era. Cold Spring Harbor Laboratory Press.

 
 

Mathur S, Suller MT, Stickler DJ, Feneley RC (2006). Prospective study of individuals with long-term urinary catheters colonized with Proteus species. BJU Int. 97:121-128.
Crossref

 
 

Meluleni GJ, Grout M, Evans DJ, Pier GB (1995). Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharides capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients. J. Immunol. 155:2029-2038.

 
 

Morgan SD, Rigby D, Stickler DJ (2009). A study of the structure of the crystalline bacterial biofilms that can encrust and block silver Foley catheters. Urological Research. 37:89-93.
Crossref

 
 

Nakonieczna J, Michta E, Rybicka M, Grinholc M, Gwizdek-Wisniewska A, Bielawski KP (2010). Superoxide dis-mutase is upregulated in Staphylococcus aureus following protoporphyrin mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment. BMC Microbiol. 10(1):323.
Crossref

 
 

Nickel JC, Ruseska I, Wright JB, Costerton JW (1985). Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27:619-624.
Crossref

 
 

Niveditha S, Pramodhini S, Umadevi S, Shailesh Kumar, Selvaraj Stephen (2012). The isolation and biofilm formation of Uropathogens in the patients with catheter Associated urinary tract infections (UTIs). J. Clin. Diagn. Res. 6:1478-1482.
Crossref

 
 

Ong CY, Ulett GC, Mabbett AN et al (2008). Identification of type 3 fimbriae in uropathogenic Escherichia coli reveals a role in biofilm formation. J. Bacteriol. 190: 1054-1063.
Crossref

 
 

Otto G, Magnusson M, Svensson M, Braconier J, Svan-borg C (2001). Pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin. Infect. Dis. 32:1523-1531.
Crossref

 
 

Petrova OE, Sauer K (2010). The novel two- component regulatory system BfiSR regulates biofilm development by controlling the small RNA rsm Z through CafA. J. Bacteriol. 192:5275-5288.
Crossref

 
 

Pramodini S (2012). Antibiotic resistance pattern of biofilm-forming uropathogenic isolated from catheterized patients in Pondicherry. India Australas. med.J. 5:344-348.
Crossref

 
 

Qin Z, Yang L, Qu D, Molin S, Tolker-Nielsen T (2009). Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis. Microbiology. 155:2148-2156.
Crossref

 
 

Raad II, Sabbagh MF, Rand KH, Sherertz RJ (1992). Quantitative tip culture methods and the diagnosis of central venous catheters related infections. Diagn. Microbiol. Infect. Dis. 15:13-20.
Crossref

 
 

Ramzan M, Bakhsh S, Salam A, Khan GM, Mustafa G (2004). Risk factors in urinary tract infection. Gomal J. Med. Sci. 2:1-4.

 
 

Reid G, Penstedt JD, Kang YS, Lam D, Nause C (1992). Microbial adhesion and biofilm formation on ureteral stents in vitro and in vivo. J. Urol. 148:1592-1594.

 
 

Rendueles O, Kaplan J, Ghigo J (2013). Antibiofilm polysaccharides. Environ. Microbiol. 15:334-346.
Crossref

 
 

Rowe MC, Withers HL, Wift S (1998). Uropathogenic Escherichia coli forms biofilm aggregates under iron restriction that disperses upon the supply of iron. FEMS Microbiol. Lett. 307:102-109.
Crossref

 
 

Roy A, Gauri SS, Bhattacharya M, Bhattacharya J (2013). Antimicrobial activity of CaO nanoparticles. J. Biomed. Nanotechnol. 9:1570-1578.
Crossref

 
 

Rupp ME, Fitzgerald T, Marion N, Helget V, Puumala S, Anderson JR, Fey PD (2004). Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am. J. Infect. Control. 32:445-450.
Crossref

 
 

Sanchez Jr CJ, Mende K, Beckius ML Akers KS, Romano DR, Wenke JC, Murray CK (2013). Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect. Dis. 13:47.
Crossref

 
 

Sano M, Hirose T, Nishimura M, Takahashi S, Mat-sukawa M, Tsukamoto T (1999). Inhibitory action of clarithromycin on glycocalyx produced by MRSA. J. Infect. Chemother. 5:10-15.
Crossref

 
 

Schmidt T, Kirsching A (2012). Total synthesis of carolacton, a highly potent biofilm inhibitor. Angew Chem. Int. Ed. 51:1063-1066.
Crossref

 
 

Sepandj F, Ceri H, Gibb Read, Olson M (2003). Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of Gram negative bacilli causing perit. Dialysis Int. 24:65-67.

 
 

Shanks R, Sargent J, Martinez R, Graber M, O'Toole G (2006). Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol. Dial. Transpl. 21:2247-2255.
Crossref

 
 

Siddiq DM, Darouiche RO (2012). New strategies to prevent catheter-associated urinary tract infections. Nat. Rev. Urol. 9:305-314.
Crossref

 
 

Stickler D, Morris N, Moreno M, Sabbuba N (1998). Studies on the formation of crystalline bacterial biofilms on urethral catheters. Euro. J. Clin. Microbiol. Infect. Dis. 17:649-652.
Crossref

 
 

Stickler DJ, Zimako J (1994). Complications of urinary tract infections associated with devices used for long-term bladder management. J. Hosp. Infect. 28:177-94.
Crossref

 
 

Stickler DJ, Morris NS, McLean RJ, Fuqua C (1998). Biofilms on indwelling urethral catheters produce quorum-sensing signal molecules in situ and in vitro. Appl. Environ. Microbiol. 64:3486-90.

 
 

Stickler DJ (2014). Clinical complications of urinary catheters caused by crystalline biofilms: something needs to be done. J Int. Med. 276:120-129.
Crossref

 
 

Stowe SD, Richards JJ, Tucker AT, Thompson R, Melander C, Cavanagh J (2011). Anti-biofilm compounds derived from marine sponges. Marine Drugs 9:2010-2035.
Crossref

 
 

Suman E, Jose J, Varghese S, Kotian MS (2005). Study of biofilm production in Escherichia coli causing urinary tract infection. Indian J. Med. Microbiol. 25:1-3.

 
 

Thomas D, Day F (2007). Biofilm formation by plant associated bacteria. Ann. Rev. Microbiol. 61:401-422.
Crossref

 
 

Tool AG Kolter R (1998). Initiation of biofilm formation in Pseudomonas fluorescence WC5365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol. Microbiol. 28:449.
Crossref

 
 

Toutain CM, Caizza NC, Zegans ME, Toole GA (2007). Roles for flagellar stators in biofilm formation by Pseudomonas aeruginosa. Res. Microb. 158:471-477.
Crossref

 
 

Trautner BW, Darouiche RO (2004). Role of biofilm in catheter-associated urinary tract infection. Am. J. Infect. Control. 32:177-183.
Crossref

 
 

Trautner BW, Hull RA, Darouiche RO (2003). Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of Uropathogens. Urology 6:1059-1062.
Crossref

 
 

Trautner RO, Darouiche RA, Hull S, Hull JI, Thornby (2002). Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus fecalis. J. Urol. 167:375-379.
Crossref

 
 

Ulett GC, Mabbett AN, Fung KC, Webb RI Schembri MA (2007). The role of F9 fimbriae of Uropathogenic Escherichia coli in Biofilm formation. Microbiology 153: 2321-2331.
Crossref

 
 

Van Acker H, Van Dijck P, Coenye T (2014). Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol. 22:326-333.
Crossref

 
 

Warren JW (2001). Catheter associated urinary tract infection. Int. J. Antimicrob. Agent. 17:299-303.
Crossref